Onkure Therapeutics Inc
OKUR2.140USD
-0.060-2.73%
Market hours （ET）Quotes delayed by 15 min
USD0.000Pre-market (ET)
28.77MMarket Cap
LossP/E TTM
Onkure Therapeutics Inc
2.140
-0.060-2.73%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2020Q2
FY2020Q1
Operating cash flows (indirect method)
Cash flow from continuing operating activities
-31.76%-14.01M
-6.39%-21.02M
87.85%-2.28M
57.76%-6.81M
-17.47%-10.63M
-26.52%-19.75M
-73.87%-18.77M
-34.78%-16.11M
-0.54%-9.05M
-55.80%-15.61M
-11.60%-10.79M
-23.25%-11.96M
-4.77%-9.00M
-85.20%-10.02M
-68.47%-9.67M
-230.30%-9.70M
-93.14%-8.59M
---5.41M
---5.74M
---2.94M
---4.45M
Net income from continuing operations
-67.00%-15.93M
-49.42%-35.19M
80.77%-3.69M
72.55%-5.36M
36.88%-9.54M
-73.19%-23.55M
-47.58%-19.20M
-58.63%-19.53M
-15.89%-15.11M
-28.22%-13.60M
-2.14%-13.01M
-33.59%-12.31M
-80.75%-13.04M
-69.63%-10.61M
-150.00%-12.73M
-149.96%-9.22M
-62.76%-7.21M
---6.25M
---5.09M
---3.69M
---4.43M
Operating gains losses
40.40%212.00K
1313.64%622.00K
-72.09%12.00K
-71.43%12.00K
268.29%151.00K
76.00%44.00K
95.45%43.00K
90.91%42.00K
115.79%41.00K
47.06%25.00K
69.23%22.00K
120.00%22.00K
90.00%19.00K
70.00%17.00K
44.44%13.00K
11.11%10.00K
11.11%10.00K
--10.00K
--9.00K
--9.00K
--9.00K
Other non-cash items
----
189.42%2.04M
78.20%-269.00K
-18.84%-675.00K
-136.34%-839.00K
-292.96%-2.29M
-3064.10%-1.23M
-878.08%-568.00K
-46.09%-355.00K
-333.73%-582.00K
-4000.00%-39.00K
-81.57%73.00K
---243.00K
--249.00K
200.00%1.00K
39700.00%396.00K
100.00%0.00
--0.00
---1.00K
---1.00K
---15.00K
Change in working capital
23.24%-1.04M
141.62%9.86M
340.21%832.00K
-165.17%-1.78M
-125.92%-1.35M
251.84%4.08M
-84.72%189.00K
467.25%2.74M
65.28%5.21M
-144.05%-2.69M
-35.03%1.24M
57.31%-745.00K
269.75%3.15M
-257.06%-1.10M
357.65%1.90M
-366.82%-1.75M
-1721.57%-1.86M
--701.00K
---739.00K
--654.00K
---102.00K
-Change in prepaid expenses
67.28%731.00K
-118.56%-1.09M
105.18%991.00K
45.37%-224.00K
-77.61%437.00K
-86.94%-501.00K
100.41%483.00K
62.93%-410.00K
-2.93%1.95M
76.37%-268.00K
121.52%241.00K
27.62%-1.11M
316.47%2.01M
-48.43%-1.13M
-732.77%-1.12M
-528.81%-1.53M
-578.10%-929.00K
---764.00K
--177.00K
---243.00K
---137.00K
-Change in payables and accrued expense
3.45%-1.68M
137.63%10.96M
69.95%-55.00K
-144.53%-1.47M
-151.15%-1.74M
298.75%4.61M
-116.46%-183.00K
593.05%3.29M
171.62%3.40M
-6344.44%-2.32M
-62.68%1.11M
300.42%475.00K
234.95%1.25M
-102.46%-36.00K
426.04%2.98M
-126.39%-237.00K
-2675.00%-927.00K
--1.47M
---914.00K
--898.00K
--36.00K
-Change in other current liabilities
150.00%40.00K
----
6.31%-104.00K
36.30%-93.00K
41.61%-80.00K
---30.00K
4.31%-111.00K
-28.07%-146.00K
---137.00K
-100.00%0.00
-363.64%-116.00K
-670.00%-114.00K
100.00%0.00
7000.00%69.00K
2300.00%44.00K
2100.00%20.00K
-100.00%-2.00K
---1.00K
---2.00K
---1.00K
---1.00K
Cash from non-recurring investing activities
Cash from operating activities
-31.76%-14.01M
-6.39%-21.02M
87.85%-2.28M
57.76%-6.81M
-17.47%-10.63M
-26.52%-19.75M
-73.87%-18.77M
-34.78%-16.11M
-0.54%-9.05M
-55.80%-15.61M
-11.60%-10.79M
-23.25%-11.96M
-4.77%-9.00M
-85.20%-10.02M
-68.47%-9.67M
-230.30%-9.70M
-93.14%-8.59M
---5.41M
---5.74M
---2.94M
---4.45M
Investing cash flow
Net cash from continuing investing activities
100.00%18.00K
100.00%50.00K
-100.00%0.00
-60.00%2.00K
-94.77%9.00K
-90.00%25.00K
-32.14%19.00K
-79.17%5.00K
290.91%172.00K
177.78%250.00K
-63.64%28.00K
300.00%24.00K
76.00%44.00K
462.50%90.00K
1000.00%77.00K
--6.00K
2400.00%25.00K
--16.00K
--7.00K
--0.00
--1.00K
Capital expenditures
100.00%18.00K
100.00%50.00K
-100.00%0.00
-60.00%2.00K
-94.77%9.00K
-90.00%25.00K
-32.14%19.00K
-79.17%5.00K
290.91%172.00K
177.78%250.00K
-63.64%28.00K
300.00%24.00K
76.00%44.00K
462.50%90.00K
1000.00%77.00K
--6.00K
2400.00%25.00K
--16.00K
--7.00K
--0.00
--1.00K
Net cash flow from disposal of fixed assets
100.00%18.00K
100.00%50.00K
-100.00%0.00
-60.00%2.00K
-94.77%9.00K
-90.00%25.00K
-32.14%19.00K
-79.17%5.00K
290.91%172.00K
177.78%250.00K
-63.64%28.00K
300.00%24.00K
76.00%44.00K
462.50%90.00K
1000.00%77.00K
--6.00K
2400.00%25.00K
--16.00K
--7.00K
--0.00
--1.00K
Net cash flow from investment products
----
-213.88%-45.33M
17.54%25.00M
132.60%22.49M
-26.35%13.76M
249.25%39.80M
146.84%21.27M
-857.72%-69.01M
241.42%18.68M
-423.51%-26.67M
-924.53%-45.41M
133.74%9.11M
--5.47M
--8.24M
-469.33%-4.43M
-2798.90%-26.99M
-100.00%0.00
--0.00
--1.20M
--1.00M
--5.20M
Cash from non-current investing activities
Net cash flow from investing activities
-100.00%-18.00K
-214.08%-45.38M
17.65%25.00M
132.59%22.49M
-100.05%-9.00K
247.77%39.78M
146.77%21.25M
-859.78%-69.01M
241.02%18.51M
-430.15%-26.92M
-907.65%-45.44M
133.65%9.08M
21808.00%5.43M
51056.25%8.15M
-477.95%-4.51M
-2799.50%-27.00M
-100.48%-25.00K
---16.00K
--1.19M
--1.00M
--5.20M
Financing cash flow
Cash flow from continuous financing activities
-870.00%-77.00K
2866.91%114.22M
1056.07%2.00M
-100.14%-89.00K
-99.01%10.00K
-1370.15%-4.13M
78.35%173.00K
148297.67%63.81M
16716.67%1.01M
173.11%325.00K
-56.31%97.00K
-99.95%43.00K
-99.99%6.00K
-99.75%119.00K
335.29%222.00K
--85.84M
177676.92%46.22M
--47.20M
--51.00K
--0.00
--26.00K
Net cash flow from debt Issuance/repayment
----
--6.00M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Net cash flow from common stock issuance/repurchase
----
1437.29%58.88M
----
-100.00%0.00
-99.01%10.00K
-2381.35%-4.40M
--0.00
--63.53M
--1.01M
765.52%193.00K
-100.00%0.00
----
----
---29.00K
--2.00K
--84.64M
----
----
----
----
----
Net cash flow from preferred stock issuance/repurchase
----
---4.33M
----
----
----
----
----
----
----
100.00%0.00
----
----
-100.00%0.00
-100.00%-1.00K
--0.00
---19.00K
--47.26M
--47.19M
----
----
--0.00
Proceeds from stock option exercised by employees
----
-90.55%26.00K
----
----
----
108.33%275.00K
78.35%173.00K
555.81%282.00K
----
-11.41%132.00K
-55.91%97.00K
--43.00K
-96.79%6.00K
1390.00%149.00K
331.37%220.00K
--0.00
619.23%187.00K
--10.00K
--51.00K
--0.00
--26.00K
Net cash flow from other financing activities
---77.00K
--53.64M
--2.00M
---89.00K
----
----
----
----
----
----
----
----
100.00%0.00
----
----
--1.22M
---1.22M
----
----
----
--0.00
Net cash from non-recurrent financing activities
Net cash from financing activities
-870.00%-77.00K
2866.91%114.22M
1056.07%2.00M
-100.14%-89.00K
-99.01%10.00K
-1370.15%-4.13M
78.35%173.00K
148297.67%63.81M
16716.67%1.01M
173.11%325.00K
-56.31%97.00K
-99.95%43.00K
-99.99%6.00K
-99.75%119.00K
335.29%222.00K
--85.84M
177676.92%46.22M
--47.20M
--51.00K
--0.00
--26.00K
Net cash flow
Beginning cash balance
270.74%110.76M
436.19%62.93M
296.10%35.97M
-32.97%20.38M
49.93%29.88M
-81.11%11.74M
-92.32%9.08M
-74.90%30.39M
-84.01%19.93M
--62.13M
-15.75%118.26M
32.75%121.09M
132.52%124.66M
-100.00%0.00
758.94%140.37M
399.05%91.22M
206.34%53.61M
--11.85M
--16.34M
--18.28M
--17.50M
Current period cash flow changes
-32.67%-14.10M
200.90%47.83M
830.69%24.72M
173.17%15.60M
-201.53%-10.63M
137.66%15.89M
104.73%2.66M
-653.14%-21.31M
393.55%10.47M
-2313.09%-42.20M
-302.12%-56.13M
-105.76%-2.83M
-109.48%-3.57M
-104.19%-1.75M
-210.41%-13.96M
2637.27%49.15M
4733.93%37.61M
--41.77M
---4.50M
---1.94M
--778.00K
Ending cash balance
402.19%96.66M
300.84%110.76M
417.07%60.69M
296.10%35.97M
-36.67%19.25M
38.67%27.63M
-81.11%11.74M
-92.32%9.08M
-74.90%30.39M
1239.34%19.93M
-50.85%62.13M
-15.75%118.26M
32.75%121.09M
-103.26%-1.75M
967.19%126.41M
758.94%140.37M
399.05%91.22M
--53.61M
--11.85M
--16.34M
--18.28M
Free cash flow
-31.82%-14.02M
-6.51%-21.07M
87.86%-2.28M
57.76%-6.81M
-15.38%-10.64M
-24.68%-19.78M
-73.59%-18.79M
-34.55%-16.12M
-1.96%-9.22M
-56.89%-15.86M
-11.01%-10.82M
-23.42%-11.98M
-4.98%-9.04M
-86.31%-10.11M
-69.61%-9.75M
-230.51%-9.71M
-93.66%-8.61M
---5.43M
---5.75M
---2.94M
---4.45M
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
